Sen. Markwayne Mullin Buys Elevance Health, Inc. (NYSE:ELV) Stock

Senator Markwayne Mullin (R-Oklahoma) recently bought shares of Elevance Health, Inc. (NYSE:ELV). In a filing disclosed on January 16th, the Senator disclosed that they had bought between $15,001 and $50,000 in Elevance Health stock on December 29th.

Senator Markwayne Mullin also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Deere & Company (NYSE:DE) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Hilton Worldwide (NYSE:HLT) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of CocaCola (NYSE:KO) on 12/29/2025.
• Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 12/29/2025.
• Purchased $100,001 – $250,000 in shares of Amazon.com (NASDAQ:AMZN) on 12/29/2025.
• Purchased $50,001 – $100,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of The Goldman Sachs Group (NYSE:GS) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Boston Scientific (NYSE:BSX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 12/29/2025.

Elevance Health Stock Performance

Shares of NYSE ELV opened at $374.86 on Friday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $83.31 billion, a P/E ratio of 15.33, a P/E/G ratio of 1.93 and a beta of 0.51. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $458.75. The stock has a 50 day moving average of $344.10 and a 200-day moving average of $328.03.

Elevance Health (NYSE:ELV) last announced its quarterly earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.03 by $1.00. Elevance Health had a return on equity of 16.17% and a net margin of 2.84%.The business had revenue of $50.09 billion during the quarter, compared to the consensus estimate of $49.26 billion. During the same quarter last year, the firm posted $8.37 EPS. The company’s quarterly revenue was up 12.0% on a year-over-year basis. As a group, equities research analysts predict that Elevance Health, Inc. will post 33.96 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ELV. Truist Financial set a $400.00 target price on Elevance Health in a research report on Tuesday, October 14th. Cowen restated a “buy” rating on shares of Elevance Health in a research note on Wednesday, November 26th. Mizuho set a $413.00 price objective on Elevance Health in a report on Friday, January 9th. Bank of America increased their price objective on Elevance Health from $330.00 to $370.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Finally, Wolfe Research set a $425.00 target price on shares of Elevance Health and gave the company an “outperform” rating in a research report on Thursday, January 8th. Thirteen investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $400.85.

Institutional Trading of Elevance Health

Institutional investors and hedge funds have recently made changes to their positions in the company. Aaron Wealth Advisors LLC lifted its stake in Elevance Health by 66.5% during the second quarter. Aaron Wealth Advisors LLC now owns 1,087 shares of the company’s stock worth $423,000 after purchasing an additional 434 shares during the last quarter. Goelzer Investment Management Inc. boosted its stake in Elevance Health by 61.7% in the second quarter. Goelzer Investment Management Inc. now owns 1,332 shares of the company’s stock valued at $518,000 after buying an additional 508 shares in the last quarter. Chesley Taft & Associates LLC grew its position in Elevance Health by 3.1% in the second quarter. Chesley Taft & Associates LLC now owns 3,804 shares of the company’s stock valued at $1,480,000 after acquiring an additional 115 shares during the last quarter. Pines Wealth Management LLC raised its stake in Elevance Health by 29.5% during the second quarter. Pines Wealth Management LLC now owns 694 shares of the company’s stock worth $270,000 after acquiring an additional 158 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC lifted its holdings in shares of Elevance Health by 11.3% in the second quarter. Dynamic Advisor Solutions LLC now owns 8,034 shares of the company’s stock worth $3,125,000 after acquiring an additional 817 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.